Cationic microparticle [poly(d,l-lactide-co-glycolide)]-coated DNA vaccination induces a long-term immune response against foot and mouth disease in guinea pigs

Journal of Gene Medicine

Volumn 14, Issue 5, 2012, Pages 348-352

  Reddy, Kotla S ^a   Rashmi, Brabhi R ^a   Dechamma, Hosur J ^a   Gopalakrishna, Susarla ^a   Banumathi, N ^a   Suryanarayana, Veluvarthy V S ^a   Reddy, Golla R ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Cationic PLG microparticles; DNA vaccines; Foot and mouth disease; Long term immunity

Indexed keywords

CATION; DNA VACCINE; FOOT AND MOUTH DISEASE VACCINE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFECT; DRUG EFFICACY; FOOT AND MOUTH DISEASE; GUINEA PIG; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; CAPSID PROTEINS; CELL-DERIVED MICROPARTICLES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC VECTORS; GUINEA PIGS; IMMUNITY, ACTIVE; INJECTIONS, INTRAMUSCULAR; LACTIC ACID; POLYGLYCOLIC ACID; VACCINES, DNA;

ANIMALIA; CAVIA;

EID: 84862110923     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2622     Document Type: Article

References (20)

1. Yang NS, Wang JH, Lin KF, et al. Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus. J Gene Med 2005; 7: 708-717.
2. Van Drunen Littel-van den Hurk S, Babiuk SL, Babiuk LA. Strategies for improved formulation and delivery of DNA vaccines to veterinary target species. Immunol Rev 2004; 199: 113-125.
3. Chaplin PJ, De Rose R, Boyle JS, et al. Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep. Infect Immun 1999; 67: 6434-6438.
4. Nobiron I, Thompson I, Brownlie J, Collins ME. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine 2003; 21: 2082-2092.
5. Rothel JS, Boyle DB, Both GW, et al. Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep. Parasite Immunol 1997; 19: 221-227.
6. Schrijver RS, Langedijk JP, Keil GM, et al. Rijsewijk.Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV. Vaccine 1997; 15: 1908-1916.
7. Jadav SK, Siva Reddy K, Rashmi BR, et al. Reddy Improved immune response by ID-pVAC: a secretory DNA vaccine construct delivered by PLG micro particles against foot and mouth disease in guinea pigs. Res Vet Sci 2011; 91: 86-89.
8. Jilek S, Merkle HP, Walter E. DNA-loaded biodegradable micro particlesas vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev 2005; 57: 377-390.
9. O'Hagan D, Singh M, Ugozzoli M, et al. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. J Virol 2001; 75: 9037-9043.
10. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992; 1: 363-369.
11. Singh M, Briones M, Ott G, O'Hagan D. Cationic microparticles: a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 2000; 97: 811-816.
12. Anonymous. Manual of Diagnostic Tests and Vaccines For Terrestrial Animals (Mammals, Birds, Bees) (5th edn edn), vol I. OIE: Paris, 2004.
13. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. Class I MHC presentation of exogenous soluble antigen via macro pinocytosis in bone marrow macrophages. Immunity 1995; 3: 783-791.
14. Kovascsovics-Bankowski M, Rock KL. A phagosome- to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995; 267: 243-246.
15. Sallusto F, Cella M, Danhelic C, Lanzavecchia AL. Dendritic cells use macropinocytosis and the mannose receptor concentrate macromolecules in the major histocompatabitility complex class II compartments; downregulation by cytokines and bacterial products. J Exp Med 1995; 182: 389-400.
16. Cox SJ, Aggarwal N, Statham RJ, Barnett PV. Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 2003; 21: 1336-1347.
17. Klavinskis LS, Barnfield C, Gao L, Parker S. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J Immunol 1999; 162: 254-262.
18. Hunter RL. Overview of vaccine adjuvants; present and future. Vaccine 2002; 20: S7-S12.
19. Todd CW, Newman MJ, Balasubramanian M. Development of adjuvant-active non ionic block copolymers. Adv Drug Deliv Rev 1998; 32: 199-223.
20. Ho TY, Hsiang CY, Hsiang C-H, Chang T-J. DNA vaccination induces a long-term antibody response and protective immunity against pseudorabiesvirus in mice. Arch Virol 1998; 143: 115-125.